Literature DB >> 1372294

Isolation and characterization of recombinant antigens from Leishmania aethiopica that react with human antibodies.

A Osland1, D Beyene, S Ashenafi, A Beetsma.   

Abstract

A genomic expression library of Leishmania aethiopica was constructed in lambda gt11 and screened with patient sera and sera from healthy people living in an area of endemicity. Forty-five recombinant clones were isolated and partly characterized. Clone-specific antibodies were prepared and used with sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western immunoblot analysis to estimate the molecular masses of the parasite-derived antigens containing the reactive epitope(s). Antigens with apparent molecular masses of 90, 85, 63, 50, 41, 25 and 24 kDa as well as several antigens with lower molecular masses were detected. The clone-specific antibodies from patients with diffuse cutaneous leishmaniasis reacted with high-molecular-weight antigens (30,000 less than Mr less than 90,000), whereas antibodies from patients with localized cutaneous leishmaniasis recognized low-molecular-weight antigens (Mr less than 25,000). Nine different purified recombinant antigens were obtained from lysogens in Escherichia coli Y1089 by immunoaffinity chromatography on anti-beta-galactosidase columns and were subsequently tested with patient sera. It is suggested that some of these recombinant antigens might be used for immunodiagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372294      PMCID: PMC257006          DOI: 10.1128/iai.60.4.1368-1374.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed.

Authors:  L L Button; D G Russell; H L Klein; E Medina-Acosta; R E Karess; W R McMaster
Journal:  Mol Biochem Parasitol       Date:  1989-01-15       Impact factor: 1.759

3.  High prevalence of elephantiasis and cutaneous leishmaniasis in Ocholo, south-west Ethiopia.

Authors:  G Mengistu; D P Humber; M Ersumo; T Mamo
Journal:  Ethiop Med J       Date:  1987-10

4.  Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis.

Authors:  A D Bryceson
Journal:  Trans R Soc Trop Med Hyg       Date:  1970       Impact factor: 2.184

5.  The parasite causing cutaneous leishmaniasis in Ethiopia.

Authors:  R S Bray; R W Ashford; M A Bray
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

6.  Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences.

Authors:  H Akuffo; E Schurr; G Andersson; T Yamaneberhan; S Britton
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

7.  Sequence arrangement of the 16S and 26S rRNA genes in the pathogenic haemoflagellate Leishmania donovani.

Authors:  W Leon; D L Fouts; J Manning
Journal:  Nucleic Acids Res       Date:  1978-02       Impact factor: 16.971

8.  Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.

Authors:  P C Melby; F A Neva; D L Sacks
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis.

Authors:  G Mengistu; H O Akuffo; T Yemane-Berhan; S Britton; T E Fehniger
Journal:  Parasite Immunol       Date:  1990-09       Impact factor: 2.280

10.  Cloning of Leishmania donovani genes encoding antigens recognized during human visceral leishmaniasis.

Authors:  H W Sheppard; D M Dwyer
Journal:  Mol Biochem Parasitol       Date:  1986-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.